These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8818387

  • 21. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
    Wang MB, Yip HT, Srivatsan ES.
    Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
    [Abstract] [Full Text] [Related]

  • 22. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines.
    Dey S, Spring PM, Arnold S, Valentino J, Chendil D, Regine WF, Mohiuddin M, Ahmed MM.
    Clin Cancer Res; 2003 Apr; 9(4):1557-65. PubMed ID: 12684432
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
    Rossi MJ, Sundararaj K, Koybasi S, Phillips MS, Szulc ZM, Bielawska A, Day TA, Obeid LM, Hannun YA, Ogretmen B.
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):55-62. PubMed ID: 15632910
    [Abstract] [Full Text] [Related]

  • 24. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y.
    Eur J Cancer; 2005 Jan; 41(2):313-22. PubMed ID: 15661558
    [Abstract] [Full Text] [Related]

  • 25. Genome-wide screening for radiation response factors in head and neck cancer.
    Singh B, Kim SH, Carew JF, Yu I, Shaha AR, Wolden S, Boyle J, Shah JP, Rao PH.
    Laryngoscope; 2000 Aug; 110(8):1251-6. PubMed ID: 10942121
    [Abstract] [Full Text] [Related]

  • 26. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model.
    Sauter ER, Herlyn M, Liu SC, Litwin S, Ridge JA.
    Clin Cancer Res; 2000 Feb; 6(2):654-60. PubMed ID: 10690551
    [Abstract] [Full Text] [Related]

  • 27. Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
    Higuchi Y, Asaumi J, Murakami J, Wakasa T, Inoue T, Kuroda M, Shibuya K, Shigehara H, Kawasaki S, Fukui K, Kishi K, Hiraki Y.
    Oncol Rep; 2002 Feb; 9(6):1233-6. PubMed ID: 12375026
    [Abstract] [Full Text] [Related]

  • 28. [Inhibitory effect of pingyangmycin on human liver cancer and stomach cancer xenografts in nude mice].
    Jiang M.
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):357-9. PubMed ID: 2470565
    [Abstract] [Full Text] [Related]

  • 29. [Treatment for recurrent head and neck carcinomas].
    Tsukuda M.
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):303-8. PubMed ID: 9492820
    [Abstract] [Full Text] [Related]

  • 30. Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients.
    Jin C, Jin Y, Wennerberg J, Rosenquist B, Mertens F.
    Mutat Res; 2008 Mar 29; 652(1):30-7. PubMed ID: 18243046
    [Abstract] [Full Text] [Related]

  • 31. Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual?
    Haikonen J, Rantanen V, Pekkola K, Kulmala J, Grénman R.
    Int J Cancer; 2003 Mar 01; 103(6):784-8. PubMed ID: 12516099
    [Abstract] [Full Text] [Related]

  • 32. Phase II clinical trial of parenteral hydroxyurea and hyper-fractionated, accelerated external beam radiation therapy in patients with advanced squamous cell carcinoma of the head and neck: toxicity and efficacy with continuous ribonucleoside reductase inhibition.
    Beitler JJ, Smith RV, Owen RP, Silver CE, Mazumdar M, Wadler S.
    Head Neck; 2007 Jan 01; 29(1):18-25. PubMed ID: 16983691
    [Abstract] [Full Text] [Related]

  • 33. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck.
    Bloom DC, Goldfarb PM.
    Eur J Surg Oncol; 2005 Nov 01; 31(9):1029-35. PubMed ID: 16150565
    [Abstract] [Full Text] [Related]

  • 34. [Peplomycin sensitivity of various types of human gynecological cultured tumor cells].
    Ueda M, Nozawa S, Ueki M, Sano T, Nagai S, Sugimoto O, Kurihara S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct 01; 36(10):1867-76. PubMed ID: 6209350
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 37. Induction of apoptosis in head-and-neck squamous carcinoma cells by gamma-irradiation and bleomycin is p53-independent.
    Patel V, Ensley JF, Gutkind JS, Yeudall WA.
    Int J Cancer; 2000 Dec 01; 88(5):737-43. PubMed ID: 11072242
    [Abstract] [Full Text] [Related]

  • 38. Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.
    Salamone FN, Gleich LL, Li YQ, Stambrook PJ.
    Laryngoscope; 2004 Apr 01; 114(4):612-5. PubMed ID: 15064612
    [Abstract] [Full Text] [Related]

  • 39. [Anticancer spectrum of pingyangmycin in vitro].
    Li XT.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun 01; 12(3):182-6. PubMed ID: 1706647
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.